Should investors sign an NDA?

    Usually not, and asking can cost you the meeting. But there is a narrow set of cases where an NDA is standard practice and refusing to ask is the mistake, the difficulty is telling them apart.

    Yash Kadam · Last reviewed 6 October 2026

    The short answer

    Most institutional investors will not sign an NDA to hear a pitch, and you should not ask. It reads as inexperience and creates friction at the exact moment you want none.

    But “no NDA for the pitch” is not the same as “no NDA ever”. Later-stage diligence, strategic and corporate investors, and anything touching unfiled IP are different situations with different norms.

    Why funds refuse, and why the reason is reasonable

    It is not arrogance. A fund looks at hundreds of companies a year, several in your category. If it signed an NDA with each, it would accumulate overlapping confidentiality obligations that make ordinary work (funding a competitor, sharing a deal with a co-investor, letting a partner who saw your deck look at an adjacent one) legally hazardous.

    There is also a practical asymmetry: a fund’s reputation is its deal flow. A firm that leaked founders’ material would stop seeing deals long before any NDA was litigated. The incentive is doing more work than the paperwork would.

    When an NDA is normal and you should ask

    Four situations where asking is expected rather than naive:

    1. Confirmatory diligence, after a term sheet. Once terms are agreed and you are opening customer contracts, salary detail and unredacted financials, a mutual NDA is standard. Many funds have their own.
    2. Strategic or corporate investors. A corporate VC whose parent competes with you is a genuinely different risk from a financial investor, and they know it. An NDA here is routine.
    3. Unfiled IP or trade secrets. If the asset is a process or formulation whose value depends on secrecy, and the filing is not yet in, you should not be disclosing it without protection, to anyone.
    4. Regulated or contractually restricted data. Sometimes the confidentiality is not yours to waive: a customer contract may oblige you to protect their data regardless of what you would prefer.

    The distinction that actually resolves it

    It is not stage or investor type. It is what you are disclosing.

    • Your pitch, market view and traction. No NDA. Your advantage is execution, not the fact that you noticed the market.
    • Your detailed operating data, usually no NDA at the pitch, but gate it rather than publishing it to everyone who asks.
    • Third-party confidential material and unfiled IP. NDA, or do not disclose. This is the line, and it is not really negotiable.

    Which is why the practical answer is usually not “NDA or no NDA” but staged access: open the pitch and headline numbers freely, keep the sensitive tier behind a deliberate grant, and attach the agreement to that tier rather than to the first conversation.

    What to do instead of asking early

    • Stage what you share. First call gets the deck and headline metrics. Diligence gets the room. Confirmatory diligence gets the sensitive tier.
    • Redact rather than withhold. A customer contract with the counterparty name masked answers most questions about your commercial terms without disclosing the counterparty.
    • Aggregate personal data. Cohort curves instead of a customer list. This is also what the DPDP Act pushes you towards. See DPDP and your investor data room.
    • Keep a record of who saw what. Far more useful than an unsigned NDA, and useful even when one is signed.

    If you do use one

    Use your agreement, drafted by your counsel for Indian law, with a governing-law and jurisdiction clause you can actually afford to rely on. A generic click-through template found online is close to decorative.

    Keep it mutual, keep the term sensible, two to three years is ordinary for commercial information, and define confidential information by category rather than by an attempt to enumerate every document.

    And record acceptance. An NDA whose signature you cannot produce, with a date, is an NDA you will struggle to enforce. In XDrop AI the NDA is your own document, gated per boardroom: nothing opens until the investor has accepted it, the acceptance is timestamped, and access can be time-limited or revoked afterwards. That is the narrow, genuine case for tooling here, not persuading funds to sign, but making the agreements you dotake enforceable and the access they govern revocable.

    What this does not mean

    None of the above is a reason to be careless. “Investors do not sign NDAs” is sometimes repeated as if confidentiality stopped mattering. It means the pitch is not protected by paperwork, not that you should hand a stranger your employee salary sheet because they expressed interest.

    A practical summary, not legal advice. Whether to use an NDA, and on what terms, depends on your facts; take advice on your own situation.

    XDrop AI is a data room for Indian fundraising, with an AI that answers investor questions and cannot read what you have not shared.

    Start free